Appili Therapeutics APLIF Stock
Appili Therapeutics Price Chart
Appili Therapeutics APLIF Financial and Trading Overview
| Appili Therapeutics stock price | 0.0020 USD |
| Previous Close | 0.002 USD |
| Open | 0.004 USD |
| Bid | 0.004 USD x 3500000 |
| Ask | 0.007 USD x 3400000 |
| Day's Range | 0.004 - 0.0068 USD |
| 52 Week Range | 0.002 - 0.02 USD |
| Volume | 36.65K USD |
| Avg. Volume | 3.04K USD |
| Market Cap | 264.73K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
APLIF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | -0.040000003 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Appili Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -88.88% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.002 USD |
| 50-Day Moving Average | 0.00626 USD |
| 200-Day Moving Average | 0.01 USD |
APLIF Share Statistics
| Avg. Volume (3 month) | 3.04K USD |
| Avg. Daily Volume (10-Days) | 1.5K USD |
| Shares Outstanding | 132.37M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0.056% |
| % Held by Institutions | 10.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.09328248 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Appili Therapeutics
| Country | United States |
| State | NS |
| City | Halifax |
| Address | 1344 Summer Street |
| ZIP | B3H 0A8 |
| Phone | 902-442-4655 |
| Website | https://appilitherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine in preclinical trials for the prevention of Francisella tularensis infection. The company has a collaboration with Vitalex Biosciences to advance VXV-01, a dual-antigen vaccine targeting invasive Candida infections. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Q&A For Appili Therapeutics Stock
What is a current APLIF stock price?
Appili Therapeutics APLIF stock price today per share is 0.0020 USD.
How to purchase Appili Therapeutics stock?
You can buy APLIF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Appili Therapeutics?
The stock symbol or ticker of Appili Therapeutics is APLIF.
Which industry does the Appili Therapeutics company belong to?
The Appili Therapeutics industry is Biotechnology.
How many shares does Appili Therapeutics have in circulation?
The max supply of Appili Therapeutics shares is 132.37M.
What is Appili Therapeutics Price to Earnings Ratio (PE Ratio)?
Appili Therapeutics PE Ratio is now.
What was Appili Therapeutics earnings per share over the trailing 12 months (TTM)?
Appili Therapeutics EPS is -0.03 USD over the trailing 12 months.
Which sector does the Appili Therapeutics company belong to?
The Appili Therapeutics sector is Healthcare.
